ExoPolyzyme

Merck Ltd.

Revision date : 2024-10-15

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

General Information

Version

8.2

Revision date

2024-10-15

Product name

ExoPolyzyme

REACH No

This

Emergency telephone

+81 (3)4531-1145, +81 (0)3 4520 9637

Icons in SDS

GHS08

Company Information

company name

Merck Ltd.

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H334

Hazard statements

Code

Statements

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

Section 2

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture Respiratory sensitization, H334: May cause allergy or asthma Category 1) symptoms or breathing difficulties if inhaled

Signal word

Danger

Hazard statements

H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.

Precautionary statements

P261 Avoid breathing dust. P284 Wear respiratory protection. P501 Dispose of contents/ container to an approved waste disposal plant.

Supplemental label elements

none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Respiratory sensitization, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.